Accessibility Menu
 
Hims & Hers Health logo

Hims & Hers Health

(NYSE) HIMS

Current Price$19.43
Market Cap$4.43B
Since IPO (2019)+98%
5 Year+50%
1 Year-28%
1 Month-25%

Hims & Hers Health Financials at a Glance

Market Cap

$4.43B

Revenue (TTM)

$2.35B

Net Income (TTM)

$128.37M

EPS (TTM)

$0.52

P/E Ratio

37.22

Dividend

$0.00

Beta (Volatility)

1.86 (High)

Price

$19.43

Volume

580,075

Open

$19.95

Previous Close

$19.43

Daily Range

$19.18 - $20.14

52-Week Range

$13.74 - $70.43

HIMS: Motley Fool Moneyball Superscore

80

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hims & Hers Health

Industry

Healthcare Providers and Services

Employees

2,442

CEO

Andrew Dudum

Headquarters

San Francisco, CA 94123, US

HIMS Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

4%

Net Income Margin

5%

Return on Equity

25%

Return on Capital

6%

Return on Assets

6%

Earnings Yield

2.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.43B

Shares Outstanding

227.94M

Volume

580.08K

Short Interest

0.00%

Avg. Volume

34.45M

Financials (TTM)

Gross Profit

$1.73B

Operating Income

$105.61M

EBITDA

$160.12M

Operating Cash Flow

$300.01M

Capital Expenditure

$226.04M

Free Cash Flow

$73.96M

Cash & ST Invst.

$577.49M

Total Debt

$1.26B

Hims & Hers Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$617.82M

+28.4%

Gross Profit

$444.44M

+20.3%

Gross Margin

71.94%

N/A

Market Cap

$4.43B

N/A

Market Cap/Employee

$2.71M

N/A

Employees

1,637

N/A

Net Income

$20.60M

-20.8%

EBITDA

$27.28M

+10.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$686.26M

-337.5%

Accounts Receivable

$32.15M

+428.8%

Inventory

$115.73M

+79.6%

Long Term Debt

$1.26B

+13213.4%

Short Term Debt

$4.84M

+156.4%

Return on Assets

5.96%

N/A

Return on Invested Capital

6.03%

N/A

Free Cash Flow

$821.00K

-98.6%

Operating Cash Flow

$64.70M

-25.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HQYHealthEquity, Inc.
$77.96-7.41%
QGENQiagen N.V.
$40.89-0.29%
TECHBio-Techne Corporation
$55.54-0.05%
BAXBaxter International Inc.
$17.15-0.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%
ZNTLZentalis Pharmaceuticals
$6.61+0.50%

Questions About HIMS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.